#neurology

All articles tagged with "neurology"

A new review says anti-amyloid Alzheimer's drugs likely do not provide clinically meaningful benefits.
The same review says the drugs increase the risk of brain bleeding and swelling.
The findings could intensify pressure on regulators, payers and developers to justify the class's risk-benefit profile.

DT Editorial Team·Apr 16, 2026·via medicalxpress.com

Phase 3 EVOKE(+) trials found semaglutide did not slow clinical progression of Alzheimer’s disease.
Earlier preclinical, observational, and small trial signals had raised hopes for GLP-1 drugs in neurodegeneration.
The negative result still helps refine future Alzheimer’s research around inflammation, vascular dysfunction, and metabolic pathways.

DT Editorial Team·Apr 1, 2026·via nature.com

MS prevalence in England more than doubled from 2000 to 2020, growing at approximately 6% per year
The increase primarily reflects better MRI-based diagnosis and longer patient survival rather than increased incidence
Disease-modifying therapies have substantially reduced excess mortality associated with MS over the study period
Treatment advances have been less effective for progressive MS than for relapsing forms, leaving a persistent care gap
Growing prevalence has significant implications for NHS capacity planning and high-cost therapy budgets

DT Editorial Team·Mar 24, 2026·via medicalxpress.com